comparemela.com
Home
Live Updates
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test : comparemela.com
Acutis Diagnostics Leverages SOPHiA GENETICS Technology to Create New Next Generation Sequencing Test
The New Assay Will Screen Patients for Clinical Trials and Help Increase Data Analysis for Clinical Researchers SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space
Related Keywords
Al Harthi ,
Abdel Halim ,
Ken Freedman ,
Nasdaq ,
Instagram ,
Facebook ,
Linkedin ,
Exchange Commission ,
Research Use ,
Twitter ,
New Assay Will Screen Patients ,
Clinical Trials ,
Help Increase Data Analysis ,
Acutis Diagnostics ,
Acutis Diagnostic ,
Hereditary Cancers Solution ,
Chief Scientific Officer ,
Executive Vice President ,
Chief Revenue Officer ,
Research Use Only ,
Looking Statements ,
Genomic Medicine ,
Acutis ,
Iagnostics ,
Beverages ,
Sophia ,
Enetics ,
Technology ,
Create ,
Text ,
Generation ,
Sequencing ,
Pest ,
comparemela.com © 2020. All Rights Reserved.